array:23 [ "pii" => "S1578219010706752" "issn" => "15782190" "doi" => "10.1016/S1578-2190(10)70675-2" "estado" => "S300" "fechaPublicacion" => "2010-06-01" "aid" => "70675" "copyright" => "Academia Española de Dermatología y Venereología and Elsevier España, S.L." "copyrightAnyo" => "2010" "documento" => "simple-article" "crossmark" => 0 "subdocumento" => "cor" "cita" => "Actas Dermosifiliogr. 2010;101:460-2" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 1921 "formatos" => array:3 [ "EPUB" => 37 "HTML" => 1078 "PDF" => 806 ] ] "itemSiguiente" => array:18 [ "pii" => "S1578219010706764" "issn" => "15782190" "doi" => "10.1016/S1578-2190(10)70676-4" "estado" => "S300" "fechaPublicacion" => "2010-06-01" "aid" => "70676" "copyright" => "Academia Española de Dermatología y Venereología and Elsevier España, S.L." "documento" => "simple-article" "crossmark" => 0 "subdocumento" => "cor" "cita" => "Actas Dermosifiliogr. 2010;101:462-4" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 2200 "formatos" => array:3 [ "EPUB" => 34 "HTML" => 1185 "PDF" => 981 ] ] "en" => array:9 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Case and research letters</span>" "titulo" => "Kaposi Sarcoma Associated With Infliximab Treatment" "tienePdf" => "en" "tieneTextoCompleto" => 0 "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "462" "paginaFinal" => "464" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Sarcoma de Kaposi asociado al tratamiento con infliximab" ] ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "M.L. Martínez-Martínez, L.J. Pérez-García, E. Escario-Travesedo, P.A. Ribera-Vaquerizo" "autores" => array:4 [ 0 => array:2 [ "nombre" => "M.L." "apellidos" => "Martínez-Martínez" ] 1 => array:2 [ "nombre" => "L.J." "apellidos" => "Pérez-García" ] 2 => array:2 [ "nombre" => "E." "apellidos" => "Escario-Travesedo" ] 3 => array:2 [ "nombre" => "P.A." "apellidos" => "Ribera-Vaquerizo" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219010706764?idApp=UINPBA000044" "url" => "/15782190/0000010100000005/v1_201304241523/S1578219010706764/v1_201304241523/en/main.assets" ] "itemAnterior" => array:18 [ "pii" => "S1578219010706740" "issn" => "15782190" "doi" => "10.1016/S1578-2190(10)70674-0" "estado" => "S300" "fechaPublicacion" => "2010-06-01" "aid" => "70674" "copyright" => "Academia Española de Dermatología y Venereología and Elsevier España, S.L." "documento" => "simple-article" "crossmark" => 0 "subdocumento" => "cor" "cita" => "Actas Dermosifiliogr. 2010;101:458-60" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 2313 "formatos" => array:3 [ "EPUB" => 32 "HTML" => 1267 "PDF" => 1014 ] ] "en" => array:9 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Case and research letters</span>" "titulo" => "Acral Syringomas" "tienePdf" => "en" "tieneTextoCompleto" => 0 "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "458" "paginaFinal" => "460" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Siringomas acrales" ] ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "M. Valdivielso-Ramos, P. de la Cueva, M. Gimeno, J.M. Hernanz" "autores" => array:4 [ 0 => array:2 [ "nombre" => "M." "apellidos" => "Valdivielso-Ramos" ] 1 => array:2 [ "nombre" => "P." "apellidos" => "de la Cueva" ] 2 => array:2 [ "nombre" => "M." "apellidos" => "Gimeno" ] 3 => array:2 [ "nombre" => "J.M." "apellidos" => "Hernanz" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219010706740?idApp=UINPBA000044" "url" => "/15782190/0000010100000005/v1_201304241523/S1578219010706740/v1_201304241523/en/main.assets" ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Case and research letters</span>" "titulo" => "Sudden Onset of Viral Warts During Treatment With Etanercept" "tieneTextoCompleto" => 0 "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "460" "paginaFinal" => "462" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "T. Sanz-Sánchez, E. Daudén, A. González-Arribas, A. García-Díez" "autores" => array:4 [ 0 => array:4 [ "nombre" => "T." "apellidos" => "Sanz-Sánchez" "email" => array:1 [ 0 => "tatiana@aedv.es" ] "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">¿</span>" "identificador" => "cor1" ] ] ] 1 => array:2 [ "nombre" => "E." "apellidos" => "Daudén" ] 2 => array:2 [ "nombre" => "A." "apellidos" => "González-Arribas" ] 3 => array:2 [ "nombre" => "A." "apellidos" => "García-Díez" ] ] "afiliaciones" => array:1 [ 0 => array:1 [ "entidad" => "Servicio de Dermatología, Hospital Universitario de la Princesa, Madrid, Spain" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor1" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Aparición brusca de verrugas virales durante el tratamiento con etanercept" ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:1 [ "bibliografiaReferencia" => array:13 [ 0 => array:3 [ "identificador" => "bib1" "etiqueta" => "1." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A global phase III randomized controlled trial of etanercept in psoriasis: safety, efficacy, and effect of dose reduction" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "K.A. Papp" 1 => "S. Tyring" 2 => "M. Lahfa" 3 => "J. Prinz" 4 => "C.E.M. Griffiths" 5 => "A.M. Nakanishi" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1365-2133.2005.06688.x" "Revista" => array:6 [ "tituloSerie" => "Br J Dermatol" "fecha" => "2005" "volumen" => "152" "paginaInicial" => "1304" "paginaFinal" => "1312" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15948997" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib2" "etiqueta" => "2." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Long-term safety and efficacy of 50 mg of etanercept twice weekly in patients with psoriasis" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "S. Tyring" 1 => "K.B. Gordon" 2 => "Y. Poulin" 3 => "R.G. Langley" 4 => "A.B. Gottlieb" 5 => "M. Dunn" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1001/archderm.143.6.719" "Revista" => array:6 [ "tituloSerie" => "Arch Dermatol" "fecha" => "2007" "volumen" => "143" "paginaInicial" => "719" "paginaFinal" => "726" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17576937" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib3" "etiqueta" => "3." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Seguridad de etanercept" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "V. García-Patos Briones" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:7 [ "tituloSerie" => "Actas Dermosifiliogr" "fecha" => "2005" "volumen" => "96" "numero" => "Supl 3" "paginaInicial" => "25" "paginaFinal" => "32" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16476328" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib4" "etiqueta" => "4." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Safety of etanercept in psoriasis: a critical review" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "J.L. Sánchez-Carazo" 1 => "L.M. Santos" 2 => "V.O. Martínez" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Drug Saf" "fecha" => "2006" "volumen" => "29" "paginaInicial" => "675" "paginaFinal" => "685" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16872241" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib5" "etiqueta" => "5." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Efficacy and safety of Etanercept in psoriasis/psoriatic arthritis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "A. Romero-Maté" 1 => "C. García-Donoso" 2 => "S. Córdoba-Guijarro" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Am J Clin Dermatol" "fecha" => "2007" "volumen" => "8" "paginaInicial" => "143" "paginaFinal" => "155" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17492843" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib6" "etiqueta" => "6." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The impact of treatment with tumour necrosis factor-alpha antagonists on the course of chronic viral infections: a review of the literature" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "S. Domm" 1 => "J. Cinatl" 2 => "U. Mrowietz" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1365-2133.2008.08851.x" "Revista" => array:6 [ "tituloSerie" => "Br J Dermatol" "fecha" => "2008" "volumen" => "159" "paginaInicial" => "1217" "paginaFinal" => "1228" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18945310" "web" => "Medline" ] ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib7" "etiqueta" => "7." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Psoriasis e infección por el virus de la inmunodeficiencia humana" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "L. Leal" 1 => "M. Ribera" 2 => "E. Daudén" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Actas Dermosifiliogr" "fecha" => "2008" "volumen" => "99" "paginaInicial" => "753" "paginaFinal" => "763" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19091213" "web" => "Medline" ] ] ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib8" "etiqueta" => "8." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Recommendations for use of etanercept in psoriasis: a European dermatology expert group consensus" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "W.-H. Boehncke" 1 => "R.A. Brasie" 2 => "J. Barker" 3 => "S. Chimenti" 4 => "E. Daudén" 5 => "M. de Rie" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1468-3083.2006.01707.x" "Revista" => array:6 [ "tituloSerie" => "J Eur Acad Dermatol Venereol" "fecha" => "2006" "volumen" => "20" "paginaInicial" => "988" "paginaFinal" => "998" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16922950" "web" => "Medline" ] ] ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib9" "etiqueta" => "9." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The human papillomavirus 16 E6 protein binds to tumor necrosis factor (TNF) R1 and protects cells from TNFinduced apoptosis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "M. Filippova" 1 => "H. Song" 2 => "J.L. Connolly" 3 => "T.S. Dermody" 4 => "P.J. Duerksen-Hughes" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1074/jbc.M200113200" "Revista" => array:6 [ "tituloSerie" => "J Biol Chem" "fecha" => "2002" "volumen" => "277" "paginaInicial" => "21730" "paginaFinal" => "21739" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11934887" "web" => "Medline" ] ] ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib10" "etiqueta" => "10." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Macrophages kill human papillomavirus type 16 E6-expressing tumor cells by tumor necrosis factor alpha- and nitric oxide-dependent mechanisms" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "J.M. Routes" 1 => "K. Morris" 2 => "M.C. Ellison" 3 => "S. Ryan" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1128/JVI.79.1.116-123.2005" "Revista" => array:6 [ "tituloSerie" => "J Virol" "fecha" => "2005" "volumen" => "79" "paginaInicial" => "116" "paginaFinal" => "123" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15596807" "web" => "Medline" ] ] ] ] ] ] ] ] 10 => array:3 [ "identificador" => "bib11" "etiqueta" => "11." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Etanercept and warts" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "D.R. Adams" 1 => "A.L. Zaenglein" 2 => "M.S. Hershey" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "J Drugs Dermatol" "fecha" => "2004" "volumen" => "3" "paginaInicial" => "601" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15624741" "web" => "Medline" ] ] ] ] ] ] ] ] 11 => array:3 [ "identificador" => "bib12" "etiqueta" => "12." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Genital HPV lesions and molluscum contagiosum occurring in patients receiving anti-TNF-alpha therapy" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "C. Antoniou" 1 => "M.G. Kosmadaki" 2 => "A.J. Stratigos" 3 => "A.D. Katsambas" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1159/000117709" "Revista" => array:6 [ "tituloSerie" => "Dermatology" "fecha" => "2008" "volumen" => "216" "paginaInicial" => "364" "paginaFinal" => "365" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18285688" "web" => "Medline" ] ] ] ] ] ] ] ] 12 => array:3 [ "identificador" => "bib13" "etiqueta" => "13." "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "Registro Español de Acontecimientos Adversos de Terapias Biológicas en Enfermedades Reumáticas (Biobadaser). [accessed October, 2008]. Available from: <a class="elsevierStyleInterRef" href="http://biobadaser.ser.es/">http://biobadaser.ser.es/</a>" ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/15782190/0000010100000005/v1_201304241523/S1578219010706752/v1_201304241523/en/main.assets" "Apartado" => array:4 [ "identificador" => "6157" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Case and Research Letters" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/15782190/0000010100000005/v1_201304241523/S1578219010706752/v1_201304241523/en/main.pdf?idApp=UINPBA000044&text.app=https://actasdermo.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219010706752?idApp=UINPBA000044" ]
Información de la revista
Vol. 101. Núm. 5.
Páginas 460-462 (junio - julio 2010)
Vol. 101. Núm. 5.
Páginas 460-462 (junio - julio 2010)
Case and research letters
Acceso a texto completo
Sudden Onset of Viral Warts During Treatment With Etanercept
Aparición brusca de verrugas virales durante el tratamiento con etanercept
Visitas
5551
T. Sanz-Sánchez
, E. Daudén, A. González-Arribas, A. García-Díez
Autor para correspondencia
Servicio de Dermatología, Hospital Universitario de la Princesa, Madrid, Spain
Este artículo ha recibido
Información del artículo
El Texto completo está disponible en PDF
References
[1.]
K.A. Papp, S. Tyring, M. Lahfa, J. Prinz, C.E.M. Griffiths, A.M. Nakanishi, et al.
A global phase III randomized controlled trial of etanercept in psoriasis: safety, efficacy, and effect of dose reduction.
Br J Dermatol, 152 (2005), pp. 1304-1312
[2.]
S. Tyring, K.B. Gordon, Y. Poulin, R.G. Langley, A.B. Gottlieb, M. Dunn, et al.
Long-term safety and efficacy of 50 mg of etanercept twice weekly in patients with psoriasis.
Arch Dermatol, 143 (2007), pp. 719-726
[3.]
V. García-Patos Briones.
Seguridad de etanercept.
Actas Dermosifiliogr, 96 (2005), pp. 25-32
[4.]
J.L. Sánchez-Carazo, L.M. Santos, V.O. Martínez.
Safety of etanercept in psoriasis: a critical review.
Drug Saf, 29 (2006), pp. 675-685
[5.]
A. Romero-Maté, C. García-Donoso, S. Córdoba-Guijarro.
Efficacy and safety of Etanercept in psoriasis/psoriatic arthritis.
Am J Clin Dermatol, 8 (2007), pp. 143-155
[6.]
S. Domm, J. Cinatl, U. Mrowietz.
The impact of treatment with tumour necrosis factor-alpha antagonists on the course of chronic viral infections: a review of the literature.
Br J Dermatol, 159 (2008), pp. 1217-1228
[7.]
L. Leal, M. Ribera, E. Daudén.
Psoriasis e infección por el virus de la inmunodeficiencia humana.
Actas Dermosifiliogr, 99 (2008), pp. 753-763
[8.]
W.-H. Boehncke, R.A. Brasie, J. Barker, S. Chimenti, E. Daudén, M. de Rie, et al.
Recommendations for use of etanercept in psoriasis: a European dermatology expert group consensus.
J Eur Acad Dermatol Venereol, 20 (2006), pp. 988-998
[9.]
M. Filippova, H. Song, J.L. Connolly, T.S. Dermody, P.J. Duerksen-Hughes.
The human papillomavirus 16 E6 protein binds to tumor necrosis factor (TNF) R1 and protects cells from TNFinduced apoptosis.
J Biol Chem, 277 (2002), pp. 21730-21739
[10.]
J.M. Routes, K. Morris, M.C. Ellison, S. Ryan.
Macrophages kill human papillomavirus type 16 E6-expressing tumor cells by tumor necrosis factor alpha- and nitric oxide-dependent mechanisms.
J Virol, 79 (2005), pp. 116-123
[11.]
D.R. Adams, A.L. Zaenglein, M.S. Hershey.
Etanercept and warts.
J Drugs Dermatol, 3 (2004), pp. 601
[12.]
C. Antoniou, M.G. Kosmadaki, A.J. Stratigos, A.D. Katsambas.
Genital HPV lesions and molluscum contagiosum occurring in patients receiving anti-TNF-alpha therapy.
Dermatology, 216 (2008), pp. 364-365
[13.]
Registro Español de Acontecimientos Adversos de Terapias Biológicas en Enfermedades Reumáticas (Biobadaser). [accessed October, 2008]. Available from: http://biobadaser.ser.es/
Copyright © 2010. Academia Española de Dermatología y Venereología and Elsevier España, S.L.